Lipoprotein(a) levels may temporarily increase during COVID-19: a pilot study

Pol Arch Intern Med. 2024 Mar 27;134(3):16707. doi: 10.20452/pamw.16707. Epub 2024 Mar 19.

Authors

Julia Warzywoda^#¹, Agnieszka Pawlos^#¹, Ewelina Woźniak¹, Marlena Broncel¹, Paulina Gorzelak-Pabiś²

Affiliations

¹ Department of Internal Diseases and Clinical Pharmacology, Laboratory of Tissue Immunopharmacology, Medical University of Lodz, Łódź, Poland
² Department of Internal Diseases and Clinical Pharmacology, Laboratory of Tissue Immunopharmacology, Medical University of Lodz, Łódź, Poland. pau.gorzelak@gmail.com

^# Contributed equally.

PMID: 38506101
DOI: 10.20452/pamw.16707

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Cholesterol, HDL
Cholesterol, LDL
Humans
Lipoprotein(a)
Pilot Projects

Substances

Lipoprotein(a)
Cholesterol, LDL
Cholesterol, HDL